Atlas Trials

Efficacy of Dapagliflozin in Early Diabetic Nephropathy in Type 1 Diabetes

Clinical trial NCT06532682 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06532682
Sponsor
The First Affiliated Hospital with Nanjing Medical University
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Diabetic Kidney DiseaseType 1 Diabetes
Start date
2024-07-01
Primary completion
2026-06-30
Enrollment
54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.